Functional Analysis Of The P160 Myb-binding Protein - A Regulator Of Multiple Transcription Factors?
Funder
National Health and Medical Research Council
Funding Amount
$376,697.00
Summary
The c-myb gene is a key molecular regulator of normal blood cell production, but alterations to this gene can also lead to leukaemia. The protein (Myb) encode by the c-myb gene acts as a transcription factor, ie, it controls the activity of other genes. There is good evidence that interactions with other proteins can regulate the activity of Myb. Our laboratory has identified what we believe is one such protein - p160 - that binds to a part of Myb that reduces its activity, and thus that is like ....The c-myb gene is a key molecular regulator of normal blood cell production, but alterations to this gene can also lead to leukaemia. The protein (Myb) encode by the c-myb gene acts as a transcription factor, ie, it controls the activity of other genes. There is good evidence that interactions with other proteins can regulate the activity of Myb. Our laboratory has identified what we believe is one such protein - p160 - that binds to a part of Myb that reduces its activity, and thus that is likely to be responsible for regulating Myb. However, it has recently become apparent that p160 interacts with a number of other transcription factors in addition Myb. The primary aim of this project is to elucidate precisely how p160 interacts with Myb and what the consequences of this interaction are. A range of experimental approaches, which range from in vitro to genetic studies, will be employed to do this. We will test a specific role of p160 suggested by our preliminary studies - that of a transporter of transcription factors between the nucleus and the cytoplasm of the cell. Because of the wide range of transcription factors that p160 interacts with, its effects on the function of the cell are likely to be profound. For this same reason, it is difficult to specifically predict the possible medical-health implications of this work However, what we know to date is consistent with a role for p160 as a tumour suppressor gene. Moreover, parts of this project aim to generate genetic information and tools which will help in determining whether p160 does play such a role and generally, in identifying any other associations of p160 with particular diseases.Read moreRead less
Understanding an exotic disease: Initiation of sex and infection by the sugarcane smut Ustilago scitaminea. Australian sugar exports generate almost $2 billion in annual sales, making the sugar industry a critical facet of the Australian economy. In 2006, Australia's primary sugar producing region came under threat when an outbreak of sugarcane smut caused by the fungus Ustilago scitaminea first appeared in Queensland. Management of this potentially devastating disease has focused on breeding pr ....Understanding an exotic disease: Initiation of sex and infection by the sugarcane smut Ustilago scitaminea. Australian sugar exports generate almost $2 billion in annual sales, making the sugar industry a critical facet of the Australian economy. In 2006, Australia's primary sugar producing region came under threat when an outbreak of sugarcane smut caused by the fungus Ustilago scitaminea first appeared in Queensland. Management of this potentially devastating disease has focused on breeding programmes aimed at developing resistant sugarcane cultivars, a complex process hampered by a lack of information about the mechanisms of smut resistance. Our research will provide key insight into the mechanisms by which U. scitaminea infects sugarcane, directing future breeding efforts and protecting this valuable industry against further outbreaks.Read moreRead less
The Establishment Of Epigenetic Marks At Metastable Epialleles In The Mouse
Funder
National Health and Medical Research Council
Funding Amount
$372,750.00
Summary
Occasionally, identical twins are found to have distinctly different characteristics, such as eye colour or severity of genetic disease, that clearly cannot be explained by their genetic makeup, and are unlikely to be the result of environmental differences. In genetically identical mice, similar cases exist, where some mice have a yellow coat and others a brown coat. In instances such as these, a growing body of evidence suggests that certain modifications to genes are responsible. These modifi ....Occasionally, identical twins are found to have distinctly different characteristics, such as eye colour or severity of genetic disease, that clearly cannot be explained by their genetic makeup, and are unlikely to be the result of environmental differences. In genetically identical mice, similar cases exist, where some mice have a yellow coat and others a brown coat. In instances such as these, a growing body of evidence suggests that certain modifications to genes are responsible. These modifications are not traditional DNA mutations, but are chemical modifications of the basic sequence. Currently, we do not know when these DNA modifications are established during foetal development. We will use the mouse coat colour gene mentioned above to investigate when the different physical characteristics are established in embryonic development. Indeed, there is increasing evidence that critical periods exist in human foetal development where minor environmental or nutritional changes can affect long-term health of the adult. Perhaps the establishment of the DNA modifications are under an environmental or nutritional influence. Further study of when and how the DNA modifications are set-up during embryonic development is necessary in order to understand these events.Read moreRead less
Genetic and epigenetic control of developmental competence. Development is an important biological process of life and understanding development has important medical and economic benefits for Australia. This research aims to study development using a simple, easily manipulated and well established experimental organism, a fungus, as a model for development in other organisms, including humans. In addition, fungi directly impact on life at many levels. Fungi can be pathogens of humans, other ani ....Genetic and epigenetic control of developmental competence. Development is an important biological process of life and understanding development has important medical and economic benefits for Australia. This research aims to study development using a simple, easily manipulated and well established experimental organism, a fungus, as a model for development in other organisms, including humans. In addition, fungi directly impact on life at many levels. Fungi can be pathogens of humans, other animals or plants significantly affecting our health, agriculture and industry. Fungi are also beneficial to other organisms, especially to many plants, and are used to manufacture pharmaceuticals and enzymes used in the health and biotechnology industries.Read moreRead less
Enhancing Grain Yield Potential and Quality of Lupin. Sustainability of wheat production in Western Australia depends on the continued use of legumes, specifically lupins, in farming systems. The low returns to growers for lupins has jeopardised these sustainable systems. This project aims to gather new information to develop novel genetic strategies to increase yield potential and modify seed composition in lupins, enhancing their commercial worth.
A Random Mutagenesis Screen To Identify Modifiers Of Epigenetic Phenomena In The Mouse.
Funder
National Health and Medical Research Council
Funding Amount
$680,750.00
Summary
In recent months, both the human and mouse genome projects have been completed. The main focus now for mammalian geneticists is to discover the function of the genes sequenced in these initiatives. One way to achieve this goal is by random mutagenesis followed by screening of mice for novel phenotypes. In the mouse, ethylnitosourea (ENU) is a chemical that can be used to perform the mutagenesis. ENU causes mutations in sperm. We are using ENU mutagenesis to search for genes that modify epigeneti ....In recent months, both the human and mouse genome projects have been completed. The main focus now for mammalian geneticists is to discover the function of the genes sequenced in these initiatives. One way to achieve this goal is by random mutagenesis followed by screening of mice for novel phenotypes. In the mouse, ethylnitosourea (ENU) is a chemical that can be used to perform the mutagenesis. ENU causes mutations in sperm. We are using ENU mutagenesis to search for genes that modify epigenetic states. Epigenetic modifications are alterations in the genome that do not change the DNA sequence, yet silence the expression of genes. Silencing occurs on a cell-by-cell basis within a tissue resulting in mosaic expression. Silencing can also occur between individuals of the same genetic makeup. For example, identical twins are occasionally found that have distinctly different characteristics, such as eye colour or severity of genetic disease. These differences may be the result of variable epigenetic modifications. However, very little is known about how these variable epigenetic modifications are controlled. We wish to find the proteins involved in establishing and maintaining epigenetic states. It is likely that these processes play a fundamental role in the determination of phenotype, both in normal development and disease.Read moreRead less
Plant transformation: exploiting anti-apoptosis genes for very high efficiency transformation. Crop improvement through genetic modification depends on the ability to transform target species. The most desirable method is Agrobacterium mediated transformation. However, plant species and cultivars differ significantly in their ability to be efficiently transformed by Agrobacterium. This is particularly true for the economically important cereals. We have discovered that anti-apoptosis genes, whic ....Plant transformation: exploiting anti-apoptosis genes for very high efficiency transformation. Crop improvement through genetic modification depends on the ability to transform target species. The most desirable method is Agrobacterium mediated transformation. However, plant species and cultivars differ significantly in their ability to be efficiently transformed by Agrobacterium. This is particularly true for the economically important cereals. We have discovered that anti-apoptosis genes, which inhibit programmed cell death, dramatically increase the Agrobacterium transformation efficiency in bananas and sugarcane. We will utilise this information and develop the use of these genes to increase the efficiency of transformation in those crops and cultivars that are difficult to transform using Agrobacterium.Read moreRead less
Differential expression and functional analysis of genes controlling metamorphosis and early neurogenesis of a model lower animal, the coral Acropora. This study will analyse, at a molecular level, the response of coral larvae to stimuli inducing settlement from the plankton and the process of establishment of a sessile, calcified colony. The knowledge gained will facilitate induction of settlement on demand in the most effective way. We will characterise known candidate genes which may be invo ....Differential expression and functional analysis of genes controlling metamorphosis and early neurogenesis of a model lower animal, the coral Acropora. This study will analyse, at a molecular level, the response of coral larvae to stimuli inducing settlement from the plankton and the process of establishment of a sessile, calcified colony. The knowledge gained will facilitate induction of settlement on demand in the most effective way. We will characterise known candidate genes which may be involved in settlement, and reveal a more complete picture using subtractive hybridisation. Studies of the nervous system and the changes that it undergoes at metamorphosis will promote understanding of the control of metamorphosis, and insights into how more complex nervous systems may have evolved.Read moreRead less
Patient Toxicity Prediction: Identification Of Mucosal Injury Mediators Using Microarray Technology
Funder
National Health and Medical Research Council
Funding Amount
$292,639.00
Summary
There is no effective way to identify all patients that will develop toxic side-effects during the course of their cancer treatment. Current pharmacogenetic testing is too narrow. This project aims to examine whole-genome profiles of patient blood to determine if risk markers of toxicity can be identified prior to beginning treatment. I will do this by comparing oesophageal cancer patients who go on to develop severe toxicity with those who only get mild treatment side-effects.